FDA Alert Curbs Enthusiasm For Hydroxychloroquine And Chloroquine
COVID-19 Treatment Should Be Limited To Clinical Trial Or Hospital Settings
A drug safety communication published by the US FDA over hydroxychloroquine and chloroquine has cooled hopes that the drugs could be used as key treatments to address the coronavirus pandemic.
